Programme · Tuesday 26 January 2027

One day. Eight sessions. Hour by hour.

Pick the sessions that interest you and build your own programme. Speakers are announced gradually.

Sessions
8
Talks
30
Speakers
8
Hours
10–18
Times are indicative until the final agenda.
OPENING
Opening addressAdonis GeorgiadisMinister of Health
  1. 10:0010:55
    01 · SCIENCE5 talks

    The science of longevity: can we slow the biological clock?

    How close are we to interventions that genuinely slow biological ageing? Which findings are well evidenced and which remain experimental? The session separates scientific potential from inflated expectations.

    • From the biology of ageing to the promise of longevity
    • Cellular senescence and biological mechanisms
    • The genetics of exceptional longevity
    • Autophagy and cellular renewal
    • Cellular resilience and ageing
  2. 10:5511:50
    02 · INSURANCE4 talks

    The socioeconomic impact: insuring a 100-year life

    How does population ageing affect insurance and pension systems? Who will fund prevention and long-term care? How are actuarial models changing? Can investment in prevention reduce future care costs?

    • Demographic pressures and public policy
    • Private insurance and longevity risk
    • Public policy and the funding of prevention
    • Pensions and demographic ageing
  3. 11:5012:45
    03 · PHARMA4 talks

    Scientific pharmacological approaches to longevity: current and future discoveries

    Can GLP-1 therapies add healthy years? Which other drug classes are at the centre of research? How are efficacy, safety and cost assessed? Where are the opportunities for the pharmaceutical industry?

    • Pharmacognosy and new active compounds
    • Metabolic health and therapeutic prospects
    • Chronic inflammation and ageing
    • Clinical management of obesity and diabetes
    12:45–13:30Break & networking
  4. 13:3014:25
    04 · DIAGNOSTICS4 talks

    Precision medicine of the future: biomarkers, genetics and artificial intelligence

    Can biological age be measured reliably? How well do genetic tools predict chronic disease? What are the real clinical applications of AI and wearables? How do evidence-based services differ from commercial promises?

    • Epidemiology and predictive biomarkers
    • Genomics and big data
    • Genetic prediction of cardiovascular risk
    • Nutrigenetics and personalised prevention
  5. 14:2515:20
    05 · CORPORATE4 talks

    Longevity at work: the 50+ workforce and return on investment

    Can corporate prevention programmes cut absence and lift productivity? How is return on investment calculated? Which practices have measurable results? How can older employees be supported without age discrimination?

    • Corporate HR practice and active working life
    • Running prevention programmes at a large employer
    • Occupational health and prevention
    • Measuring outcomes and ROI
  6. 15:2016:15
    06 · SILVER ECONOMY4 talks

    Silver economy: the over-60s as active consumers

    How are consumer patterns changing? What opportunities are emerging in senior living, travel, natural products and healthy-ageing services? What evidence sits behind anti-ageing claims? How can Greek companies build products with real value?

    • Demographic change and new consumer patterns
    • Dermo-aesthetics, quality of life and healthy ageing
    • Product development and new healthy-ageing markets
    • New business models for the over-60s
    16:15–16:30Coffee & booth visits
  7. 16:3017:15
    07 · INVESTMENT2 talks

    Longevity investing: startup showcase

    How is the development of longevity technologies and services funded? What do investors look for in a longevity company? What does it take to bring a scientific discovery to market?

    • Start-up pitches
    • Discussion with investors
  8. 17:1518:00
    08 · EU FUNDING3 talks

    EU Healthier Together: where the European funding is

    What funding is available to research institutions, companies and health organisations? How are partnerships built for prevention and long-term care? What are the eligibility criteria and the real opportunities to take part?

    • European programmes and long-term care
    • Funding instruments and open calls
    • Research and development bodies

The programme and speakers may change. "My programme" is stored on this device only.

All speakers

26.01.2027 · Athens

One day.
The next era of health.

Register now